Biotricity Inc

biotricity.com

What Do They Do?

Provides cardiac monitoring devices, software and remote monitoring services to healthcare providers and consumers.

How Do They Make Money?

Medical centers and physicians buy wearable monitoring devices directly. Biotricity earns technology fees based on customer use of its software, at a fixed rate when a cardiac study is complete and issued to the physician.

revenue

Segment	Share	Revenue	How money arrives
Technology Fees Usage-based	90% FY2023: 91%		Usage-based
Device Sales Sold outright	9.7% FY2023: 8.7%		Sold outright

Who Are Their Customers?

Medical centers and physicians buy devices directly; clinics, hospitals and independent diagnostic testing facilities use the tools to provide cardiac studies.

Customers above 10% of revenue, FY2026

of revenue from two customers (20%, 10%)

FY2025: 29% from one customer

Do Revenues Turn Into Profits?

No. It lost $2.4M in FY2026.

Operating income, FY2026

11% of revenue

▲ Now profitable vs FY2025 (−$2.4M, −18%)

Net income, FY2026

−15% of revenue

▼ −71% (Loss) vs FY2025 (−$8.4M, −61%)

How Are They Changing?

Since the FY2026 annual report

Latest quarter: Q1 FY2027, the three months to Jun 30, 2026

Revenue: ▲ +10%; vs $3.9M in Q1 FY2026
Net income: ▲ +43% (Loss); vs −$672K in Q1 FY2026

Technology Fees share of revenue vs 87.0% in Q1 FY2026

Growing. Revenue grew 2.1x in 4 years, from $7.7M in FY2022 to $16M in FY2026, about 20% a year.

Cellular monitoring device The earlier report describes Biotres as a three-lead cardiac monitor; the latest describes its cellular version, Biocore Pro, as the company's flagship technology.

Revenue over time

Technology Fees Device Sales Service Related and Other Revenue

$20M$10M$0

FY2022 FY2023 FY2024 FY2025 FY2026

Who Do They Compete With?

Competes with BioTelemetry, Boston Scientific, Preventice, ScottCare, Infobionic, VitalConnect, Medtronic, iRhythm Technologies, BardyDx, Alivecor, Optimize Health, and HelloHeart

Comments